Hospital
Ogallala Community Hospital
Ogallala Community Hospital was paid $1.20M by Medicaid between Jan 2018 and Jun 2024, across 43 billing codes. Its largest line is 99284, emergency room visit (serious) — 23% of everything it billed.
33Billing provider infoOGALLALA COMMUNITY HOSPITAL
OGALLALA, NE 69153
OGALLALA, NE 69153
33aNPI1710915467assigned 06/30/2006
33bProvider typeCritical Access Hospital
28Total paid$1.20M
24GClaims19,564
24DCodes billed43
24AFirst – last monthJan 2018 – Jun 2024
Compared with peers
Next to other Critical Access Hospital providers in Nebraska
Rank by total paid#11 of 53
Median peer was paid$593K
This provider vs. median2.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,725 | $165K | |
| 2019 | 3,774 | $215K | |
| 2020 | 2,393 | $167K | |
| 2021 | 4,227 | $241K | |
| 2022 | 4,122 | $318K | |
| 2023 | 1,137 | $81K | |
| 2024incomplete | 186 | $9K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 23% | 1,333 | 1,015 | $269K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 1,359 | 1,145 | $230K |
| 80053 | Comprehensive metabolic panel | 12% | 2,998 | 2,476 | $146K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 11% | 2,072 | 1,734 | $129K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.5% | 2,961 | 2,429 | $66K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.1% | 139 | 109 | $49K |
| 84443 | Thyroid stimulating hormone (TSH) | 3.7% | 1,132 | 932 | $45K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 3.3% | 660 | 604 | $40K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.0% | 288 | 261 | $35K |
| J3490 | Unclassified drugs | 2.3% | 1,496 | 689 | $28K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.3% | 415 | 366 | $27K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.2% | 669 | 337 | $26K |
31 more codes
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.4% | 281 | $17K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 105 | $9K |
| 87631 | <1% | 54 | $9K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 94 | $8K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 343 | $8K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,323 | $7K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 128 | $6K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 83 | $6K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 98 | $5K |
| 80061 | Lipid panel | <1% | 129 | $4K |
| 81001 | <1% | 244 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 113 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 38 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 84 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 86 | $2K |
| 86140 | <1% | 72 | $2K | |
| 85027 | <1% | 66 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 39 | $1K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 359 | $1K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 15 | $1K |
| 71045 | Radiologic examination, chest; single view | <1% | 16 | $868.57 |
| 81003 | <1% | 102 | $864.77 | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 12 | $750.42 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 16 | $630.92 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 33 | $598.03 |
| 85610 | <1% | 30 | $394.85 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 17 | $292.12 |
| A9270 | Non-covered item or service | <1% | 15 | $290.23 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 16 | $267.50 |
| 82043 | <1% | 15 | $176.32 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 16 | $76.31 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGULLINGSRUD, TIMOTHY (CEO)
Parent organizationBANNER HEALTH
| Provider | Location | Paid |
|---|---|---|
| Ogallala Community Hospital | Ogallala, NE | $515K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.